Average Insider

Where insiders trade, we follow

Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ€“ Chief Financial Officer
May 6, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$3.43
Current$16.2761.6% above low, 38.4% below high
Sale$18.5572.6% above low, 27.4% below high
52W High$24.27
Shares
13,834
Price
$18.55
Total Value
$256,655.28

Nearby Earnings

No earnings within 2 weeks of this transaction.

Transaction Details

InsiderSullivan Christopher Ryan
TitleChief Financial Officer
Transaction DateMay 6, 2026
Transaction CodeS Sale
Acquired/DisposedDisposed
Security
Common Stock
Direct/IndirectDirect
Filing DateMay 7, 2026
Shares Sold13,834
Price per Share$18.55
Total Value$256,655.28
Shares Owned After33,589
DerivativeNo
Accession Number0001810417-26-000010
DocumentView SEC Filing
Version: v26.5.2